Health Care
Commentary
Dr. Henry Miller Answers Viewer Questions as Featured Expert on Fox News Live Blog
Read answers from PRI Senior Fellow Dr. Henry Miller on Foxnews.com’s “Coronavirus Live Blog.” Dr. Miller answered written questions on Wednesday, April 1 about the coronavirus, next steps, and more. Read Dr. Miller’s responses here: https://www.foxnews.com/health/coronavirus-live-blog-former-fda-official-dr-henry-miller.
Charter Schools
Coronavirus school shutdowns foster online learning alternatives
Along with other sectors of society, education has been greatly affected by the coronavirus, with schools closed across America. Yet, as in other fields, innovators in education have responded with learning mechanisms and models that allow students to continue to learn while the country shuts down brick-and-mortar institutions. As it ...
Blog
Amidst Coronavirus-Fueled Economic Downturn, State Leaders Must Suspend Government Barriers to Opportunity
In his “Breaking Down Barriers to Opportunity” series, PRI’s Dr. Wayne Winegarden has argued that one of the most important ways that elected officials can help to lift people up the economy ladder is by embracing policies that encourage entrepreneurship. As many Californians struggle to stay afloat financially during the ...
Drug Pricing
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
Commentary
Expand Pharmacists’ Authority To Promote Access To Forthcoming COVID-19 Vaccine
Private pharmaceutical companies and the National Institutes of Health have outdone themselves. Thanks to the funding provided by the NIH, a Phase 1 clinical trial for a COVID-19 vaccine is underway. In separate efforts, Inovio, Sanofi, Vaxart, GlaxoSmithKline, and Johnson & Johnson are all developing potential vaccines. In total, “about 35 companies ...
Business & Economics
Mark Skousen – On These Uncertain Times
Dr. Mark Skousen is one of the most prominent libertarians in the country and founder of FreedomFest – the largest gathering of libertarians in the world. Dr. Skousen also teaches economics at Chapman University. In this podcast, we discuss the economic impact of the coronavirus, the financial markets, politics, California, ...
Coronavirus
John Batchelor and Dr. Henry Miller Discuss the Importance of Serology Tests in Coronavirus Fight
Dr. Henry Miller joins the John Batchelor Show to discuss the importance of gathering data and testing from people who have recovered from the coronavirus. Dr. Miller talks about an example from the United Kingdom of doctors testing patients who recovered from COVID-19 without showing symptoms.
Commentary
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that ...
Blog
Single Payer Poll Watch: Coronavirus Update
Coronavirus is impacting everything and anything it touches. In the March PRI Single Payer Poll Watch, average opposition to a single payer plan overtook support, continuing the trend of growing opposition to a single payer health care plan PRI noticed in our first poll watch in December 2019. With the ...
Commentary
A Surprise in the Congressional Stimulus Package?
A proposed fix for surprise medical bills may end up on the cutting-room floor as negotiations over the multi trillion-dollar economic stimulus package wrap up on Capitol Hill. Last week, Sen. Lamar Alexander, R-Tenn., and Rep. Frank Pallone, D-N.J., were trying to get their plan, which would essentially cap bills ...
Dr. Henry Miller Answers Viewer Questions as Featured Expert on Fox News Live Blog
Read answers from PRI Senior Fellow Dr. Henry Miller on Foxnews.com’s “Coronavirus Live Blog.” Dr. Miller answered written questions on Wednesday, April 1 about the coronavirus, next steps, and more. Read Dr. Miller’s responses here: https://www.foxnews.com/health/coronavirus-live-blog-former-fda-official-dr-henry-miller.
Coronavirus school shutdowns foster online learning alternatives
Along with other sectors of society, education has been greatly affected by the coronavirus, with schools closed across America. Yet, as in other fields, innovators in education have responded with learning mechanisms and models that allow students to continue to learn while the country shuts down brick-and-mortar institutions. As it ...
Amidst Coronavirus-Fueled Economic Downturn, State Leaders Must Suspend Government Barriers to Opportunity
In his “Breaking Down Barriers to Opportunity” series, PRI’s Dr. Wayne Winegarden has argued that one of the most important ways that elected officials can help to lift people up the economy ladder is by embracing policies that encourage entrepreneurship. As many Californians struggle to stay afloat financially during the ...
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
Expand Pharmacists’ Authority To Promote Access To Forthcoming COVID-19 Vaccine
Private pharmaceutical companies and the National Institutes of Health have outdone themselves. Thanks to the funding provided by the NIH, a Phase 1 clinical trial for a COVID-19 vaccine is underway. In separate efforts, Inovio, Sanofi, Vaxart, GlaxoSmithKline, and Johnson & Johnson are all developing potential vaccines. In total, “about 35 companies ...
Mark Skousen – On These Uncertain Times
Dr. Mark Skousen is one of the most prominent libertarians in the country and founder of FreedomFest – the largest gathering of libertarians in the world. Dr. Skousen also teaches economics at Chapman University. In this podcast, we discuss the economic impact of the coronavirus, the financial markets, politics, California, ...
John Batchelor and Dr. Henry Miller Discuss the Importance of Serology Tests in Coronavirus Fight
Dr. Henry Miller joins the John Batchelor Show to discuss the importance of gathering data and testing from people who have recovered from the coronavirus. Dr. Miller talks about an example from the United Kingdom of doctors testing patients who recovered from COVID-19 without showing symptoms.
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that ...
Single Payer Poll Watch: Coronavirus Update
Coronavirus is impacting everything and anything it touches. In the March PRI Single Payer Poll Watch, average opposition to a single payer plan overtook support, continuing the trend of growing opposition to a single payer health care plan PRI noticed in our first poll watch in December 2019. With the ...
A Surprise in the Congressional Stimulus Package?
A proposed fix for surprise medical bills may end up on the cutting-room floor as negotiations over the multi trillion-dollar economic stimulus package wrap up on Capitol Hill. Last week, Sen. Lamar Alexander, R-Tenn., and Rep. Frank Pallone, D-N.J., were trying to get their plan, which would essentially cap bills ...
